期刊文献+

头孢丙烯对5种儿童感染常见病原菌的抗菌活性 被引量:4

Antibacterial activity of cefprozil against five common pathogens isolated from pediatric patients
下载PDF
导出
摘要 目的观察头孢丙烯等口服抗生素对5种儿童社区获得性感染常见致病菌的体外抗菌活性。方法选取近年北京儿童医院临床分离的金葡菌、化脓性链球菌、肺炎链球菌、流感嗜血杆菌和卡他莫拉菌菌株,采用E试验法检测其对头孢丙烯、头孢克洛、头孢地尼等抗生素的敏感性。结果头孢丙烯对所检测菌株的MIC90值分别是:甲氧西林敏感金葡菌0.75mg/L;化脓性链球菌0.023mg/L;肺炎链球菌青霉素敏感株0.094mg/L,青霉素耐药株12mg/L;β内酰胺酶阴性流感嗜血杆菌2mg/L,β内酰胺酶阳性16mg/L;β内酰胺酶阴性卡他莫拉菌0.75mg/L,β内酰胺酶阳性2mg/L。PRSP株对头孢丙烯耐药率为61.9%,流感嗜血杆菌β内酰胺酶阳性株中占15.8%。结论头孢丙烯对金葡菌、化脓性链球菌、青霉素敏感肺炎链球菌、β内酰胺酶阴性卡他莫拉菌有良好抗菌作用;对β内酰胺酶阳性流感嗜血杆菌的抗菌活性低于头孢地尼;青霉素耐药肺炎链球菌株对头孢丙烯有较高的耐药率。 Objective To study the in vitro antimicrobial activity of cefprozil against five common bacterial pathogens causing community-acquired pediatric infections. Methods The tested bacterial strains isolated from patients in Beijing Children's Hospital included Staphylococcus aureus (77 = 50), Streptococcus pneumoniae (n = 74), Streptococcus pyogenes ( n = 30), Haemophilus influenzae (n=30) and Moraxella catarrhalis (n=30). Minimum inhibitory concentrations (MICs) of cefprozil, cefaclor and several other antimicrobials against these strains were determined using E test method. Results MICro of cefprozil was 0.75 mg/L against methicillin-sensitive S. aureus, 0. 023 mg/L against S. pyogenes, 0. 094 (penicillin-susceptible S. pneumaniae, PSSP) to 12 mg/L (penicillin-resistant S. pneumoniae, PRSP) against S. pneumoniae, 2 (beta-lactamase negative strain) to 16 mg/L (beta-lactamase positive strain) against H. influenzae and 0.75 (beta-lactamase-negative strain) to 16 mg/L (beta-lactamase positive strain) against M. catarrhalis isolates respectively. About 61.9%of PRSP isolates and 15.8% of beta-lactamase positive H. influenzae strains were resistant to cefprozil respectively. Conclusions Our results suggest that cefprozil has good in vitro activity against methieillin-sensitive S. aureus, S. pyogenes, PSSP, and beta-lactamase negative M. catarrhalis isolates. But it is not as active as cefdinir against beta-lactamase positive H. influenzae. Relatively higher proportion of PRSP isolates is resistant to cefprozil.
出处 《中国抗感染化疗杂志》 2005年第5期275-277,共3页 Chinese Journal of Infection and Chemotherapy
基金 国家自然科学基金(No.30271377) 科技部十五攻关课题(2003BA712A11-20)
关键词 头孢丙烯 细菌 抗生素 敏感性 Cefprozil Bacteria Antimicrobial Activity
  • 相关文献

参考文献10

  • 1Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential[J]. Drugs, 1993, 45: 295-317.
  • 2Christenson JC, Swenson E, Gooch WM, et al. Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis[J]. Antimicrob Agents Chemother, 1991, 35:1127-1130.
  • 3张菁,曹忆堇,郁继诚,施耀国,张婴元.头孢丙烯临床药代动力学和干混悬剂与片剂的生物等效性[J].中国抗感染化疗杂志,2001,1(2):87-88. 被引量:13
  • 4Fung-Tomc JC, Huczko E, Stickle T, et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides[J]. Antimicrob Agents Chemother, 1995,39: 533-538.
  • 5Zhanel GG, Palatnick L, Nichol KA, et al. Antimicrobial resistance in Haemophilus influenza and Moraxella catarrhalis Respiratory track isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002[J]. Antimicrob Agents Chemother, 2003,47: 1875-1881.
  • 6Pankuch GA, Davies TA, Jacobs MR, et al. Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents[J]. Antimicrob Agents Chemother, 2002, 46:42-46.
  • 7Clark CL, Nagai K, Dewasse BE, et al. Activity of cefditoren against respiratory pathogens [J]. J Antimicro Chemoth,2002, 50: 33-41.
  • 8沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 9Gupta N,Mukherjee A,Moharana AK. Pediatric tonsillopharyngitis- an evaluation of cefprozil in Indian patients[J]. Indian J Pediatr, 2004, 71: 601-605.
  • 10Bhargava S, Lodha R, Kabra SK. Cefprozil:a review[J].Indian J Pediatr 2004, 70:395-400.

二级参考文献12

  • 1[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011.
  • 2[5]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38(1): 40-43.
  • 3[6]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard[S]. Fifth edition. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. 2001.
  • 4[7]Saino Y, Kobayash F, Inoue M, et al. Purification and properties of inducible penicillin-beta-lactamase isolates from Pseudomonas maltophilia[J]. Antimicrob Agents Chemother, 1982, 22: 564-570.
  • 5[8]Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems[J]. Antimicrob Agents Chemother, 1996, 40(2): 349-353.
  • 6戴自英 刘裕昆 汪复.实用抗菌药物学[M](第2版)[M].上海:上海科学技术出版社,1997.153-160.
  • 7Barriere SL. Review of in vitro activity,pharmacokinetic characteristics, safety and clinical efficacy of cefproil, a new oral cephalosporin[J]. Ann Pharmacother, 1993, 27(9): 1082-1089.
  • 8Barbhaiya RH,Shukla UA, Gleason CR, et al, Phase I study of multiple-dose cefprozil and comparison with cefaclor[J]. Antimicrob Agents Chemother,1990,34(6): 1198-1203.
  • 9Wise R. The pharmacokinetics of the oral cephalosporins:a review[J]. J Antimicrob Chemother,1990, 26(Suppl E): 13-20.
  • 10刘长庭,王德龙,秦荧,王俊峰.不同年代老年气管切开患者铜绿假单胞菌对抗生素耐药性分析[J].中华医院感染学杂志,2002,12(6):419-421. 被引量:43

共引文献120

同被引文献19

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部